<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e>/<z:mp ids='MP_0001845'>inflammation</z:mp> appears to be an important predisposing risk factor for <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, but little is known regarding underlying molecular mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the hypothesis that patients with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> preceded by <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>/<z:mp ids='MP_0001845'>inflammation</z:mp> within 1 week could be identified by a distinctive procoagulant laboratory profile characterized by abnormalities in the protein C system and endogenous fibrinolysis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We performed a case-control study examining the relationship between preceding systemic infectious/inflammatory syndromes and selected immunohematologic variables in 36 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and 81 control subjects (community control subjects [n = 47] and hospitalized nonstroke neurological patient controls [n = 34]) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The <z:hpo ids='HP_0001297'>stroke</z:hpo> group had a lower mean level of the circulating antithrombotic enzyme activated protein C (APC) (4.33 +/- 0.34% [log-transformed percentage of control value, mean +/- SD]) than community control subjects (4.51 +/- 0.27%, P &lt; .02) or hospitalized neurological patient controls (4.57 +/- 0.31%, P &lt; .005) </plain></SENT>
<SENT sid="4" pm="."><plain>The lowest circulating APC levels were found in the <z:hpo ids='HP_0001297'>stroke</z:hpo> group with antecedent <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>/<z:mp ids='MP_0001845'>inflammation</z:mp> within 1 week preceding index <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (4.23 +/- 0.4%, n = 12) </plain></SENT>
<SENT sid="5" pm="."><plain>Within the <z:hpo ids='HP_0001297'>stroke</z:hpo> group, circulating APC levels were inversely related to IgG isotype anticardiolipin antibody titers (r = -.55, P &lt; .001) </plain></SENT>
<SENT sid="6" pm="."><plain>Only the <z:hpo ids='HP_0001297'>stroke</z:hpo> group with <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>/<z:mp ids='MP_0001845'>inflammation</z:mp> within 1 week had elevated plasma C4b binding protein compared with control subjects (141 +/- 61% versus 112 +/- 44%, P &lt; .05) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> patients with antecedent <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>/<z:mp ids='MP_0001845'>inflammation</z:mp> had a distinctively lower ratio of active tissue plasminogen activator to plasminogen activator inhibitor (0.11 +/- 0.04, n = 9) than other <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (0.19 +/- 0.06, n = 9, P &lt; .01) and control subjects (0.22 +/- 0.16, n = 17, P &lt; .02) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Impairments in the protein C pathway and endogenous fibrinolysis may contribute to the increased risk for <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> after recent (&lt; or = 1 week) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>/<z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>A decrease in the circulating <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> APC may be related to elevated <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> titers </plain></SENT>
</text></document>